Bank of Montreal
VKTX icon

Bank of Montreal’s Viking Therapeutics VKTX Stock Holding History

Bank of Montreal’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,000
Closed -$401K – 4752
2019
Q4 		$401K Hold
50,000
– – ﹤0.01% 2788
2019
Q3 		$344K Hold
50,000
– – ﹤0.01% 2630
2019
Q2 		$415K Buy
50,000
+18,100
+57% +$155K ﹤0.01% 2527
2019
Q1 		$317K Buy
31,900
+5,000
+19% +$41.9K ﹤0.01% 2508
2018
Q4 		$206K Buy
+26,900
New +$322K ﹤0.01% 2560

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of Montreal's VKTX Position: Q4 2024 in Review

Bank of Montreal sold out of Viking Therapeutics (VKTX) in Q4 2024, closing a stake of 35,252 shares — an estimated $2.17M sold.

Bank of Montreal first reported a position in VKTX in Q2 2018 and held it in 18 quarters. The position peaked at $3.24M in Q4 2019. 408 funds tracked by Wall St. Rank hold VKTX as of Q4 2024.

  • Bank of Montreal reported no remaining Viking Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 35,252 Viking Therapeutics shares in Q4 2024, an estimated $2.17M.
  • Bank of Montreal first reported a position in Viking Therapeutics in Q2 2018 and held it in 18 quarters.
  • Bank of Montreal's Viking Therapeutics position peaked at $3.24M in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.